Innovative US healthcare company Signify Health making headlines in Ireland
The past seven months have seen exciting developments for US health tech company Signify Health which has opened a technology centre in Galway.
StoryLab is delighted to partner with this innovative business to help raise its profile in Ireland with job announcements, the opening of the technology centre, leadership appointments and visits by senior management to Ireland.
Signify Health is a U.S. healthcare technology platform with a mission is transform the U.S. healthcare market and the Galway technology centre, announced in March, will be key to creating and innovating the technology to achieve that.
The company, which was founded in 2017, is dual-headquartered in New York and Dallas, Texas and is publicly traded on the New York Stock Exchange.
It employs more than 2,000 people in the US and is currently actively recruiting team members in Ireland from software engineers to product managers and other technology development positions.
The Irish team will be based at Bonham Quay in Galway City where some 125 jobs will be created by the end of next year. They will be responsible for developing new solutions through software development and large-scale data analytics.
In April, Elaine Murphy was announced as Director of Signify Health’s Galway operations followed in May by the appointment of another Galway woman Michelle Concannon as Senior Vice President of Engineering.
In September, there was a lot of media interest in the visit to Galway by Signify’s senior management — including CEO Kyle Armbrester, CTO Josh Builder and CPO Paymon Farazi — who held significant meetings with IDA Ireland and the University of Galway.
Signify Health has been featured across all major news outlets since launching in Ireland – from news stories, in The Sunday Business Post, The Irish Examiner, and Business Plus, to more in-depth interviews in the Sunday Independent, The Irish Times, Silicon Republic as well as on Galway Bay FM and Ocean FM, to name just a few.